Any patient with active malignancy, uncontrolled metabolic disease, or a history of endocrine tumors is not a candidate for GH-stimulating peptide therapy
Feel stronger, sharper, more energized
Summary of key findings: In vitro: reduced oxidative stress, improved cell function
Testosterone influences energy, Journal of Clinical Endocrinology & Metabolism Growth Hormone Declines ~14% Per Decade After 30 Human growth hormone production decreases approximately 14% per decade after age 30
The peptide accelerates regeneration of intestinal mucosa and submucosa, restores tight junction proteins (claudin-1, occludin, ZO-1) that fail in intestinal permeability syndromes, and increases local blood supply through VEGF-mediated angiogenesis
You should always carefully evaluate all available information and consult Elders or another advisor further before you commit to any course of action or rely on any recommendation